Jeffrey D. Capello, a director at Neogen Corp. ($NEOG), made one open market purchase of common shares in the last 365 days, totaling just over $100,000. His most recent buy occurred on April 22, 2025. This ranks him 2,210th among nearly 5,000 individual insiders by purchase amount, below the average of $1.46 million across about 3.3 transactions per insider. Capello reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 27, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 1777 | $6.19 | 1,777.0000 | 217,298,626 | 50.00% | 0.00% |
| Oct. 27, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock | 1777 | $6.19 | 32,502.0000 | 217,298,626 | 5.78% | 0.00% |
| Oct. 27, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 2025 | $6.19 | 4,050.0000 | 217,298,626 | 33.33% | 0.00% |
| Oct. 27, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock | 2025 | $6.19 | 30,725.0000 | 217,298,626 | 7.06% | 0.00% |
| Oct. 23, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | A | Common Stock (Right to Buy) | 50814 | $0.00 | 50,814.0000 | 217,298,626 | 9999.99% | 0.02% |
| Oct. 23, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | A | Common Stock | 19769 | $6.07 | 48,469.0000 | 217,298,626 | 68.88% | 0.01% |
| Oct. 7, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 2071 | $5.63 | 0.0000 | 217,298,626 | 100.00% | 0.00% |
| Oct. 7, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock | 2071 | $5.63 | 28,700.0000 | 217,298,626 | 7.78% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Restricted stock units | 2861 | $0.00 | 2,861.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 18, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Stock options (right to buy) | 15768 | $0.00 | 15,768.0000 | 74,103,192,000 | 9999.99% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Restricted stock units | 2120 | $0.00 | 0.0000 | 74,103,192,000 | 100.00% | 0.00% |
| June 20, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Common stock | 2120 | $0.00 | 6,073.0000 | 74,103,192,000 | 53.63% | 0.00% |
| June 13, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Restricted stock units | 1977 | $0.00 | 1,976.0000 | 74,103,192,000 | 50.01% | 0.00% |
| June 13, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Common stock | 1977 | $0.00 | 3,953.0000 | 74,103,192,000 | 100.05% | 0.00% |
| April 22, 2025 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | P | Common Stock | 20712 | $4.84 | 26,629.0000 | 216,944,017 | 350.04% | 0.01% |
| Oct. 28, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock | 1776 | $13.81 | 5,917.0000 | 216,698,138 | 42.89% | 0.00% |
| Oct. 28, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 1776 | $13.81 | 3,552.0000 | 216,698,138 | 33.33% | 0.00% |
| Oct. 24, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | A | Common Stock (Right to Buy) | 18653 | $0.00 | 18,653.0000 | 216,698,138 | 9999.99% | 0.01% |
| Oct. 24, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | A | Restricted Stock Units | 6075 | $13.58 | 15,840.0000 | 216,698,138 | 62.21% | 0.00% |
| Oct. 7, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock | 2070 | $15.07 | 4,141.0000 | 216,698,138 | 99.95% | 0.00% |
| Oct. 7, 2024 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 2070 | $15.07 | 2,071.0000 | 216,698,138 | 49.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Stock options (right to buy) | 11774 | $0.00 | 11,774.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Restricted stock units | 2120 | $0.00 | 2,120.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Restricted stock units | 1976 | $0.00 | 3,953.0000 | 72,967,922,000 | 33.33% | 0.00% |
| June 13, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | M | Common stock | 1976 | $0.00 | 1,976.0000 | 72,967,922,000 | 9999.99% | 0.00% |
| Oct. 26, 2023 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Common Stock (Right to Buy) | 13716 | $0.00 | 32,132.0000 | 216,245,501 | 74.48% | 0.01% |
| Oct. 26, 2023 | NEOGEN CORP | $NEOG | CAPELLO JEFFREY D | Director | M | Restricted Stock Units | 5329 | $0.00 | 9,470.0000 | 216,245,501 | 128.69% | 0.00% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Restricted stock units | 5929 | $0.00 | 5,929.0000 | 71,256,118 | 9999.99% | 0.01% |
| June 13, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | CAPELLO JEFFREY D | Director | A | Stock options (right to buy) | 33177 | $0.00 | 33,177.0000 | 71,256,118 | 9999.99% | 0.05% |